ORIC Pharmaceuticals Inc.

NASDAQ: ORIC · Real-Time Price · USD
9.78
-0.15 (-1.51%)
At close: Aug 15, 2025, 1:30 PM

ORIC Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
59.41M 23.38M 66.84M 226.01M
Short-Term Investments
196.55M 184.8M 139.43M 10.97M
Long-Term Investments
n/a 26.85M 21.95M 43.39M
Other Long-Term Assets
8.97M 552K 11.52M 12.32M
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
6.29M 4.41M 4.18M n/a
Total Current Assets
262.25M 212.6M 210.46M 240.52M
Property-Plant & Equipment
2.92M 12.01M 3.25M 2.41M
Goodwill & Intangibles
n/a n/a -3.18M -3.41M
Total Long-Term Assets
11.89M 39.41M 36.72M 58.12M
Total Assets
274.14M 252.01M 247.18M 298.64M
Account Payables
1.55M 944K 1.32M 1.89M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
3.18M 2.75M 2.66M 1.93M
Other Current Liabilities
-3.18M 3.78M -2.66M -1.93M
Total Current Liabilities
24.85M 20.46M 15.39M 15.15M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a 10.52M
Total Long-Term Liabilities
6.17M 7.46M 9.44M 10.52M
Total Liabilities
31.02M 27.92M 24.83M 25.67M
Total Debt
9.36M 10.21M 2.66M 1.93M
Common Stock
7K 6K 5K 4K
Retained Earnings
-562.77M -434.93M -334.23M -245.11M
Comprehensive Income
379K 258K -1.29M -103K
Shareholders Equity
243.12M 224.09M 222.35M 272.98M
Total Investments
196.55M 211.66M 161.38M 54.36M